|Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia|
J Shepherd, SM Cobbe, I Ford, CG Isles, AR Lorimer, PW Macfarlane, ...
New England Journal of Medicine 333 (20), 1301-1308, 1995
|Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial|
J Shepherd, GJ Blauw, MB Murphy, ELEM Bollen, BM Buckley, SM Cobbe, ...
The Lancet 360 (9346), 1623-1630, 2002
|Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials|
N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ...
The Lancet 375 (9716), 735-742, 2010
|Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study|
N Sattar, A Gaw, O Scherbakova, I Ford, DSJ O’Reilly, SM Haffner, C Isles, ...
Circulation 108 (4), 414-419, 2003
|Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study|
DJ Freeman, J Norrie, N Sattar, RDG Neely, SM Cobbe, I Ford, C Isles, ...
Circulation 103 (3), 357-362, 2001
|Recommendations for the standardization and interpretation of the electrocardiogram: part I: the electrocardiogram and its technology a scientific statement from the American …|
P Kligfield, LS Gettes, JJ Bailey, R Childers, BJ Deal, EW Hancock, ...
Journal of the American College of Cardiology 49 (10), 1109-1127, 2007
|The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with …|
J Belch, A MacCuish, I Campbell, S Cobbe, R Taylor, R Prescott, R Lee, ...
Bmj 337, 2008
|Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)|
C Packard, J Shepherd, S Cobbe, I Ford, CG Isles, JH McKillop, ...
Circulation 97 (15), 1440-1445, 1998
|Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing …|
BJ Drew, RM Califf, M Funk, ES Kaufman, MW Krucoff, MM Laks, ...
Circulation 110 (17), 2721-2746, 2004
|The diagnostic performance of computer programs for the interpretation of electrocardiograms|
JL Willems, C Abreu-Lima, P Arnaud, JH van Bemmel, C Brohet, ...
New England Journal of Medicine 325 (25), 1767-1773, 1991
|Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies|
N Sattar, A McConnachie, AG Shaper, GJ Blauw, BM Buckley, ...
The Lancet 371 (9628), 1927-1935, 2008
|Long-term follow-up of the West of Scotland Coronary Prevention Study|
I Ford, H Murray, CJ Packard, J Shepherd, PW Macfarlane, SM Cobbe
New England Journal of Medicine 357 (15), 1477-1486, 2007
PW Macfarlane, A Van Oosterom, O Pahlm, P Kligfield, M Janse, J Camm
Springer Science & Business Media, 2010
|AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction a scientific statement from the American …|
GS Wagner, P Macfarlane, H Wellens, M Josephson, A Gorgels, ...
Journal of the American College of Cardiology 53 (11), 1003-1011, 2009
|A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs|
S Luo, K Michler, P Johnston, PW Macfarlane
Journal of electrocardiology 37, 81-90, 2004
|Recommendations for standardization and specifications in automated electrocardiography: bandwidth and digital signal processing. A report for health professionals by an ad hoc …|
JJ Bailey, AS Berson, A Garson Jr, LG Horan, PW Macfarlane, ...
Circulation 81 (2), 730-739, 1990
|Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland …|
N Sattar, O Scherbakova, I Ford, DSJ O’Reilly, A Stanley, E Forrest, ...
Diabetes 53 (11), 2855-2860, 2004
|The design of a prospective study of pravastatin in the elderly at risk (PROSPER)|
J Shepherd, GJ Blauw, MB Murphy, SM Cobbe, ELEM Bollen, BM Buckley, ...
The American journal of cardiology 84 (10), 1192-1197, 1999
|Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial|
JGF Cleland, DJ Pennell, SG Ray, AJ Coats, PW Macfarlane, GD Murray, ...
The Lancet 362 (9377), 14-21, 2003
|Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study.|
AG Shaper, SJ Pocock, M Walker, AN Phillips, TP Whitehead, ...
Journal of Epidemiology & Community Health 39 (3), 197-209, 1985